Dose Range Assessment

Dose Range Assessment is a methodological framework within pharmacokinetic analysis that characterizes the relationship between administered drug dose and systemic exposure to evaluate the proportional changes in pharmacokinetic parameters across a specified dose range.

114

Publications

5.9K

Citations

667

Authors

247

Institutions

Publications per year

2017–2026

Parents

Dose-proportionality Analysis

Publications

114

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 329 citations · Full text

Medicine, Oncology, Pharmacology +16

BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial

Ronald N. Marcus, Peter J. Goadsby, David W. Dodick et al. · Cephalalgia · 2013 · 292 citations

Medicine, Pharmacology, Pharmacotherapy +16

Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.

Clinton J. Grubbs, V E Steele, Tamara L. Casebolt et al. · PubMed · 1995 · 238 citations

Medicine, Pharmacology, Toxicology +15

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

Xiaochen Zhao, Satyendra Suryawanshi, Matthew Hruska et al. · Annals of Oncology · 2017 · 235 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The Dose Determines the Stimulation (and Poison): Development of A Chemical Hormesis Database

Edward J. Calabrese, Linda A. Baldwin · International Journal of Toxicology · 1997 · 202 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

1–5 of 114

Authors

667

WE
W. Enghardt
Helmholtz-Zentrum Dresden-Rossendorf, Germany
3 publications · 226 citations
3
h-index
FF
F. Fiedler
Helmholtz-Zentrum Dresden-Rossendorf, Germany
3 publications · 226 citations
3
h-index
MB
Michael Barker
Health Canada, Canada
2 publications · 72 citations
2
h-index
JA
Jennifer A. Low
National Cancer Institute, United States
2 publications · 360 citations
2
h-index
JH
James H. Doroshow
National Cancer Institute, United States
2 publications · 360 citations
2
h-index

1–5 of 667

Institutions

247

1–8 of 247

Venues

PubMed
Repository · 11 publications · 617 citations
11
h-index
Journal of Clinical Oncology
7 publications · 482 citations
7
h-index
Antimicrobial Agents and Chemotherapy
AAC · 4 publications · 186 citations
4
h-index
Toxicologic Pathology
4 publications · 107 citations
4
h-index
British Journal of Clinical Pharmacology
BJCP · 3 publications · 98 citations
3
h-index

1–5